Report for: Radiofrequency Ablation versus Resection for Colorectal Cancer Liver Metastases: A Meta-Analysis

Title	Radiofrequency Ablation versus Resection for Colorectal Cancer Liver Metastases: A Meta-Analysis
Published in	PLOS ONE, September 2012
DOI	10.1371/journal.pone.0045493
Pubmed ID	23029051
Authors	Mingzhe Weng, Yong Zhang, Di Zhou, Yong Yang, Zhaohui Tang, Mingning Zhao, Zhiwei Quan, Wei Gong
Abstract	No randomized controlled trial (RCT) has yet been performed to provide the evidence to clarify the therapeutic debate on liver resection (LR) and radiofrequency ablation (RFA) in treating colorectal liver metastases (CLM). The meta-analysis was performed to summarize the evidence mostly from retrospective clinical trials and to investigate the effect of LR and RFA.

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Germany	1	50%
Unknown	1	50%

Type	Count	As %
Members of the public	1	50%
Science communicators (journalists, bloggers, editors)	1	50%

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Ph. D. Student	12	14%
Other	11	13%
Researcher	9	11%
Student > Master	9	11%
Student > Bachelor	8	9%
Other	24	28%
Unknown	12	14%

Readers by discipline	Count	As %
Medicine and Dentistry	53	62%
Engineering	2	2%
Social Sciences	2	2%
Biochemistry, Genetics and Molecular Biology	2	2%
Business, Management and Accounting	2	2%
Other	6	7%
Unknown	18	21%

PLOS